A blog exploring pharmaceutical relationship marketing, emarketing and innovation with a focus on rare disorders.
The convergence of rare disease, digital communications, and pharmaceutical marketing communications

Profiles >> Pamela Todd Archives

Delivering Value in Rare Diseases

Posted by | 10:56am on Monday, February 29, 2016 | No Comments
Hidden Value of Orphan Drugs

Debates about high drug prices have dominated many of the headlines this year.  Raise the price of a drug 5,000% and you will definitely get everyone’s attention, including the feds.

It’s unfortunate to see the occasional bad actors getting so much press, given the inspiring progress made by all of the companies and communities diligently working to find treatments, especially when you consider those with rare diseases. Thirty million people in America are impacted by rare disease and 95% of those disorders lack treatment. Don’t let the headlines mislead you. The real news is that continued investment in rare disease innovation helps everyone.

We hope you’ll share our 4th annual Rare Disease Infographic that focuses on these innovations:

  • Record levels of investment leading to record levels of FDA approvals
  • NIH and advocacy groups funding early research
  • Research on orphan drugs that opens the door to new treatments for common ailments
  • New distribution models that reduce costs through direct patient engagement and personal support
  • Foundations and compliance experts working to accelerate the approval process by improving research and public policy

As the number of orphan drug designations and approvals rises, there will likely be more questions raised about the cost.  The customary response is that research is more challenging in rare diseases or that knowledge gained from rare informs the common, both of which are true.

But as the emphasis on reducing costs in healthcare grows, perhaps the best response orphan drug makers can make is to demonstrate value. That isn’t just about costs.  It’s about patient experience, quality of care and maximizing outcomes.

Understanding how best to accomplish this requires a paradigm shift. Delivering value in orphan drugs requires a fundamentally different strategy, because rare patients and families face a whole host of financial, medical and lifestyle challenges that require a sophisticated system of support.

In the end, it will be the patients themselves that teach us what good looks like in rare disease. Whether it’s a matter of determining meaningful endpoints for clinical trials or designing a program to increase adherence, the best way to deliver value is to listen to them.

Caregiver supporting child

Who Cares for the Caregiver?

November is National Caregivers Month. It’s also a good time to think about what you are offering this under recognized,…

Tags: , , , , , ,


How Should Pharma Navigate the Landscape of Compassionate Use?

For companies that operate in the rare disease space, compassionate use policies are critical. Rare disease patients and caregivers are…

Tags: , ,


What the FDA’s New Social Media Guidance Means for Marketers

Little by little, and in no particular order, the FDA is rolling out new recommendations for use of internet and…

Tags: ,


Rare Diseases and the Promise of Genetics

Sharon Moalem, MD, PhD, is not just an award-winning researcher and physician, the founder of 2 biotech companies, and the…

From Patient Partner to Patient Leader

Remember when patients were passive receivers of care and the only thing that mattered was what the doctor thought? Neither…


Why Transparency Matters More Than Ever

Relationships are important in rare—and so are reputations. Rare disease communities are often small and closely knit. Patients and caregivers…

Tags: , , , ,

5 Ways to Speed Diagnosis of Our Children

You have probably heard the statistics before. There are 7,000 rare diseases. More than 80% are genetic. Half of those…

Tags: , , , , ,

NJ RARE 2013 Jane Castello Julie Raskin Francois Nader Debbie Hart Mary Cobb

Rare Disease and the Power of Partnership

One of the issues raised by the Affordable Care Act is the importance of decisions made at the state level…

Tags: , ,

What Patient-Centricity Means to Marketers

In 2011, when Lilly and Disney teamed up to create a series of books for kids with type 1 diabetes,…

Tags: , , , , ,


Hacking the Diagnosis of Rare Diseases

Ed Fennell is a problem solver. After spending 35 years running a private consulting business, he’s turned his attention to…

Tags: , , ,

Creating Hope for Undiagnosed Patients

Most rare disease patients spend a good portion of their lives coping with a condition that is either undiagnosed or…

Tags: , , ,


A Search Engine To Help Diagnose Rare Diseases

If you are trying to diagnose a rare disease, plugging symptoms into Google will probably not be very helpful. In…

Tags: , , , ,

Why Rare Disease Caregivers Inspire Me

If you want to know the heights of love, compassion, determination, and self-sacrifice that people can rise to, just sit…

Tags: , ,


An Unstoppable Rare Disease Mom

Lisa Moreno-Dickinson may not have made Forbes’ list of the world’s most powerful people this year. But that is not…

Tags: , , , ,

New Resources That Will Help Speed Diagnosis of Rare Diseases

The rare community has made huge strides in the 30 years that have elapsed since the Orphan Drug Act was…

Tags: , , , ,

question mark

Diagnosis Is A Cause Everyone Can Get Behind

One of the most moving moments (and there were many of them) at Global Genes’ recent patient advocacy summit was…

Tags: , , , , , ,

Get Ready for Healthcare Reform

During a recent phone call arranged by the National Organization for Rare Disorders (NORD) to help members prepare for healthcare…

Tags: , ,


Say Hello to Doctor Digital Omnivore

In a recent post, How Caregivers are Different Than Other Health Seekers, we noted that caregivers are more likely to…

Tags: , , ,

Geolocating a Cure for a Rare Disease

U.S.  Senator Tom Udall of New Mexico has introduced a bill that could be a bellwether for rare disease communities….

Tags: , , ,

Hands Clapping

Reaching Rare Disease Communities

Every once in awhile you stumble on a phrase that perfectly captures one of your  principles – something you’ve been…

Tags: , , , , , ,

How Caregivers are Different Than Other Health Seekers

One of the things that is different about the world of rare disorders is the power and influence of caregivers…

question mark graffitti

What Do Patients Want From Pharma?

If it seems like we are always asking ourselves this question, that’s probably a good thing. All relationships require nurturing…


Crowdsourcing Cures

The medical research community is waking up to something that people with rare disorders have understood for a long time:…


How to Reach Caregivers

The latest Pew Internet health report provides some powerful insights into an audience that is key for many rare disease…


Time to Mobilize Your Resources?

If you’ve been watching the growth in smartphone adoption and wondering whether or not you should be considering mobile in…

Tags: ,

Your Nurse Audience is Growing

Registered nurses (RNs), nurse practitioners (NPs), and physician assistants (PAs) will all play increasingly important roles in health care during…

Tags: ,

Are Medical Apps for You?

The adoption of mobile applications (apps) is impressive, especially given that they’ve only been around for two years. In July…


Lost Medical Data Dress

Why Empowered Patients Are the Future of Medicine

The launch of the Community Health Data Initiative is one of those watershed moments that we will one day look…


Why Compassion Makes Good Business Sense

Before you venture into social media, it’s a good idea to think about who will share your message. But more…

Tags: ,

Siren Interactive
  • Siren Interactive
  • Rare Disease Relationship Marketing Experts
  • 626 West Jackson Blvd, Suite 100
  • Chicago, IL 60661
  • 312.204.6700
  • 866.502.6714 (Toll Free)
  • www.sireninteractive.com